MINNEAPOLIS, May 9, 2018 /PRNewswire/ — Preventice Solutions announced today the launch of the BodyGuardian® Mini, the smallest, reusable long-term Holter technology available for cardiac monitoring. The new, compactly designed technology includes an ultra-small, lightweight cardiac monitor that enables up to 14-days of ECG measurements that are transmitted to a physician in an […]
Rhythm
CardioFocus Announces Successful Live Case Featuring HeartLight® X3 System
MARLBOROUGH, Mass., May 9, 2018 /PRNewswire/ — CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced a successful live case featuring its breakthrough HeartLight X3 System during the annual Prague Workshop on Catheter Ablation. Building upon the advanced features […]
Bardy Diagnostics™ Announces Validation of AI-Enabled Automatic Screening Technology for Atrial Fibrillation
SEATTLE, May 9, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s only P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device, presented a poster today titled “Artificial Intelligence for the Automatic Detection of […]
Data Reinforce Reduced Complications with Medtronic Micra Transcatheter Pacing System Over Traditional Pacemakers in Real-World Use
DUBLIN and BOSTON – May 9, 2018 – Medtronic plc (NYSE: MDT) today announced that results through 12-months from the Post-Approval Registry (PAR) for the Medtronic Micra(TM) Transcatheter Pacing System (TPS), reinforcing the high implant success rate and low complication rate seen since its U.S. approval two years ago, will be […]
Results from Imricor MRI-Guided Cardiac Ablation Study to Be Presented at Heart Rhythm Society Conference in Boston
MINNEAPOLIS–(BUSINESS WIRE)– Imricor Medical Systems announced today that the results from the clinical study to evaluate Imricor’s Vision-MRTM Ablation Catheter for the treatment of atrial flutter under real-time MRI guidance will be presented this week at the Heart Rhythm Society (HRS) conference in Boston. Philipp Sommer MD will present the study results on […]
NRG® Transseptal Needle Associated with a 40% Lower Risk of Silent Cerebral Embolism
TORONTO, May 8, 2018 /PRNewswire/ – A recent study published in Heart and Vessels has found that the use of the Baylis Medical NRG® radiofrequency (RF) Transseptal Needle for transseptal punctures was linked to a 40% lower incidence of silent acute cerebral embolism in atrial fibrillation (AF) ablation procedure patients.1 The study publication follows a […]
Heart Rhythm Society Kicks Off Annual Scientific Sessions In Boston To Unveil Scientific Advances And Innovations In Cardiac Arrhythmia Care
BOSTON, May 8, 2018 /PRNewswire/ — Thousands of clinicians, scientists, researchers and innovators from around the world will gather together Wednesday, May 9 through Saturday, May 12 at the Boston Convention and Exhibition Center for Heart Rhythm 2018, the Heart Rhythm Society’s (HRS) 39th Annual Scientific Sessions, to explore recent developments in the field of cardiac pacing […]
First Cardiac Procedure Using the AcQMap® System by Acutus Medical® Successfully Performed in the United States
CARLSBAD, Calif., May 8, 2018 /PRNewswire/ — Acutus Medical®, a global heart rhythm technology company, today announced that the AcQMap® High Resolution Imaging and Mapping System has been utilized for the first time in U.S. patients. The company also revealed initiation of a new clinical study to evaluate the technology during atrial fibrillation retreatment […]
Cardiva Medical Announces Completion of the AMBULATE Pivotal Trial Evaluating the VASCADE MVP System for Multi-Vessel Closure Following Electrophysiology Procedures
SANTA CLARA, Calif.–(BUSINESS WIRE)–Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced the completion of the AMBULATE pivotal trial, one of several clinical trials in the company’s AMBULATE series that are studying the VASCADE MVP Venous Vascular Closure System for use in the closure of mid-bore […]
Affera’s Novel Technology For Cardiac Arrhythmia Treatment To Be Featured In 8 Scientific Sessions At The 2018 Heart Rhythm Society Meeting
WATERTOWN, Mass., May 7, 2018 /PRNewswire/ — Affera, Inc, a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today its integrated platform will be highlighted in eight scientific sessions at the Heart Rhythm Society 2018 (HRS) meeting in Boston, Massachusetts. Affera’s revolutionary lesion formation technology offers a solution designed to optimize procedural efficiency […]



